NYSE: RCUSArcus Biosciences Inc Stock Ownership - Who owns Arcus Biosciences?
Insider buying vs selling
Have Arcus Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Terry J. Rosen | Chief Executive Officer | 2025-02-27 | 19,800 | $10.18 | $201.47kBuy |
| Yasunori Kaneko | Director | 2025-02-27 | 20,000 | $10.06 | $201.20kBuy |
| Gilead Sciences Inc | 10% Owner | 2025-02-18 | 1,363,636 | $11.00 | $15.00MBuy |
| Ii Robert C. Goeltz | Chief Financial Officer | 2024-12-31 | 3,594 | $15.00 | $53.91kSell |
| Alexander Azoy | Chief Accounting Officer | 2024-12-19 | 3,007 | $15.17 | $45.62kSell |
| Jennifer Jarrett | Chief Operating Officer | 2024-12-15 | 27,501 | $16.08 | $442.22kSell |
| Dimitry Sa Nuyten | Chief Medical Officer | 2024-12-15 | 7,856 | $16.08 | $126.32kSell |
| Alexander Azoy | Chief Accounting Officer | 2024-12-15 | 2,969 | $16.08 | $47.74kSell |
| Ii Robert C. Goeltz | Chief Financial Officer | 2024-12-15 | 10,099 | $16.08 | $162.39kSell |
| Juan C. Jaen | President | 2024-12-15 | 17,286 | $16.08 | $277.96kSell |
RCUS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RCUS insiders and whales buy or sell their stock.
RCUS Shareholders
What type of owners hold Arcus Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Gilead Sciences Inc | 29.68% | 31,424,760 | $290.36M | Insider |
| Gilead Sciences Inc | 29.68% | 31,424,760 | $290.36M | Institution |
| Terry J. Rosen | 13.91% | 14,731,646 | $136.12M | Insider |
| Blackrock Inc | 10.26% | 10,867,091 | $100.41M | Institution |
| Vanguard Group Inc | 6.32% | 6,687,800 | $61.80M | Institution |
| Woodline Partners LP | 4.84% | 5,127,304 | $47.38M | Institution |
| Fmr LLC | 4.21% | 4,456,846 | $41.18M | Institution |
| State Street Corp | 3.49% | 3,696,479 | $34.16M | Institution |
| Gv 2016 GP LLC | 2.95% | 3,125,312 | $28.88M | Insider |
| Point72 Asset Management LP | 2.71% | 2,867,097 | $26.49M | Institution |
RCUS vs Biotech Stocks
Arcus Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.